中华肾病研究电子杂志
中華腎病研究電子雜誌
중화신병연구전자잡지
Chinese Journal of Kidney disease investigation (Electronic Version)
2015年
5期
223-226
,共4页
少见肾脏病%病理诊断%临床资料%发病机理%治疗
少見腎髒病%病理診斷%臨床資料%髮病機理%治療
소견신장병%병리진단%림상자료%발병궤리%치료
Rare kidney disease%Pathological diagnosis%Clinical data%Pathogenesis%Treatment
改革开放30余年来,经几代肾脏病学者的艰苦努力和攀登,我国肾脏病事业取得了飞速发展,对常见的肾脏疾病、特别是肾小球疾病的诊治取得了长足的进步,某些研究领域己逐步与国际接轨。但基于我国肾脏病研究基础薄弱、地广人多,发展很不平衡,因此提升我国少见肾脏病的诊治水平尚有很大空间,加强少见肾脏病的临床和基础研究仍任重而道远。本文就如何提高我国少见肾脏病诊治水平提出几点看法:(1)认真做好肾活检病理检查,重视免疫病理和电镜在病理诊断中的作用。强调制片、染色质量,光镜、免疫荧光和电镜检查不应缺失任何一项,互为补充进行综合判断。提倡临床病理讨论会,病理学家与临床专家互动,是提高少见肾脏病诊断率和正确性的有效方法。(2)重视临床资料收集和分析,结合基因检测,提高少见肾脏病的诊断率,防止误诊、漏诊。重视病史(包括家族史)和临床资料(查体、实验室及相关医学影像检查结果)收集,并加以认真分析;在此基础上应努力开展与疾病相关的特殊检查,对于疑似遗传性肾病患者应做遗传基因检测,避免把少见的继发性肾脏病和遗传性疾病漏诊或误诊为原发性肾脏病。(3)对危害性大的少见肾脏病积极开展流行病学调查和发病机制的研究,以期深入阐明其发病机制。(4)组织好高水平临床治疗研究,以期获得高质量循证医学证据,指导和提高我国整体肾脏病的临床治疗水平。(5)强调依据患者具体病情制定个体化治疗方案和充分发挥中医中药优势,努力提高我国少见肾脏病的疗效。
改革開放30餘年來,經幾代腎髒病學者的艱苦努力和攀登,我國腎髒病事業取得瞭飛速髮展,對常見的腎髒疾病、特彆是腎小毬疾病的診治取得瞭長足的進步,某些研究領域己逐步與國際接軌。但基于我國腎髒病研究基礎薄弱、地廣人多,髮展很不平衡,因此提升我國少見腎髒病的診治水平尚有很大空間,加彊少見腎髒病的臨床和基礎研究仍任重而道遠。本文就如何提高我國少見腎髒病診治水平提齣幾點看法:(1)認真做好腎活檢病理檢查,重視免疫病理和電鏡在病理診斷中的作用。彊調製片、染色質量,光鏡、免疫熒光和電鏡檢查不應缺失任何一項,互為補充進行綜閤判斷。提倡臨床病理討論會,病理學傢與臨床專傢互動,是提高少見腎髒病診斷率和正確性的有效方法。(2)重視臨床資料收集和分析,結閤基因檢測,提高少見腎髒病的診斷率,防止誤診、漏診。重視病史(包括傢族史)和臨床資料(查體、實驗室及相關醫學影像檢查結果)收集,併加以認真分析;在此基礎上應努力開展與疾病相關的特殊檢查,對于疑似遺傳性腎病患者應做遺傳基因檢測,避免把少見的繼髮性腎髒病和遺傳性疾病漏診或誤診為原髮性腎髒病。(3)對危害性大的少見腎髒病積極開展流行病學調查和髮病機製的研究,以期深入闡明其髮病機製。(4)組織好高水平臨床治療研究,以期穫得高質量循證醫學證據,指導和提高我國整體腎髒病的臨床治療水平。(5)彊調依據患者具體病情製定箇體化治療方案和充分髮揮中醫中藥優勢,努力提高我國少見腎髒病的療效。
개혁개방30여년래,경궤대신장병학자적간고노력화반등,아국신장병사업취득료비속발전,대상견적신장질병、특별시신소구질병적진치취득료장족적진보,모사연구영역기축보여국제접궤。단기우아국신장병연구기출박약、지엄인다,발전흔불평형,인차제승아국소견신장병적진치수평상유흔대공간,가강소견신장병적림상화기출연구잉임중이도원。본문취여하제고아국소견신장병진치수평제출궤점간법:(1)인진주호신활검병리검사,중시면역병리화전경재병리진단중적작용。강조제편、염색질량,광경、면역형광화전경검사불응결실임하일항,호위보충진행종합판단。제창림상병리토론회,병이학가여림상전가호동,시제고소견신장병진단솔화정학성적유효방법。(2)중시림상자료수집화분석,결합기인검측,제고소견신장병적진단솔,방지오진、루진。중시병사(포괄가족사)화림상자료(사체、실험실급상관의학영상검사결과)수집,병가이인진분석;재차기출상응노력개전여질병상관적특수검사,대우의사유전성신병환자응주유전기인검측,피면파소견적계발성신장병화유전성질병루진혹오진위원발성신장병。(3)대위해성대적소견신장병적겁개전류행병학조사화발병궤제적연구,이기심입천명기발병궤제。(4)조직호고수평림상치료연구,이기획득고질량순증의학증거,지도화제고아국정체신장병적림상치료수평。(5)강조의거환자구체병정제정개체화치료방안화충분발휘중의중약우세,노력제고아국소견신장병적료효。
Since the reform and opening up 3 decades ago,China′s nephrology has made great achivements after hard work of several generations of Chinese nephrologists;in the diagnosis and treatment for common kidney diseases,especially glomerular diseases,striking progress has been made;and China′s nephrology in some research fields has geared to the international conventions.But as the study foundation of kidney diseases in China is weak,with widespread population and very uneven development,there is still much space for improving China′s diagnosis and treatment of rare kidney diseases,and there is still a long way to go to enhance clinical and basic researches on rare kidney diseases.To achieve this goal,we put forward the following opinions:1 .Standardization of renal biopsy pathologic examination,paying attention to the roles of the immune pathology,and electron microscopy in pathological diagnosis.We emphasize on high quality production and dyeing of pathological specimen;and light microscopy,immunofluorescence,and electron microscopy are all indispensable and mutually complementary.We advocate clinical pathological conference to promote interactions between pathologists and clinical experts.2.Attaching great importance to the collection and analysis of clinical data,combining genetic screening to effectively improve the diagnosis of rare kidney diseases,and prevent misdiagnosis and failure to diagnose.We emphasize on complete collection of illness history (including familial history)and clinical data (including physical,laboratory, and related medical image examinations)for serious analysis;on the basis of the above,disease-relevant special examination and gene detection for patients with suspected inherited kidney diseases should be performed,in order to avoid failure to diagnose rare secondary renal diseases and genetic diseases or misdiagnosing them as primary kidney diseases.3.We also advocate active epidemiological investigation and the pathogenesis researches on very harmful rare kidney diseases so as to elucidate the pathogenesis.4.We should organize high quality clinical therapeutic trials to obtain high quality evidence-based medical data for the purpose of providing guidance and improving the treatment of rare kidney diseases in China.5.We emphasize individualized treatment and giving full play to the advantages of traditional Chinese medicine for improving the efficacy of rare kidney diseases.